A Medical Device Daily
UTI (Collegeville, Pennsylvania) said it has changed its name to Accellent. Last June, the company acquired MedSource Technologies (Minneapolis), making the combined entity one of the world's largest medical device outsource manufacturing, design and engineering organizations (Medical Device Daily, July 2, 2004).
Accellent said its headquarters will be located in the Boston area, while its Collegeville facility will remain a key manufacturing center. The company employs more than 3,500 people in 20 specialized facilities in five countries.
“We wanted to create a new identity to encompass the significant value we offer our customers and the leadership we bring to medical device outsourcing,“ said Ron Sparks, president and CEO. “The combination of UTI and MedSource has created an organization with unprecedented scale, scope of services and the ability to invest and grow in new technologies not previously achieved in the industry.“
He added: “With one of the most comprehensive service offerings in the industry, we can now effectively manage the entire supply chain for our customers — from early stage design to end-user delivery.“
The Endoscopy division, led by George Trutza — formerly of Surgicon and U.S. Surgical — develops, manufactures and assembles implants and instruments used in minimally invasive surgeries and procedures.
Under the executive leadership of Daniel Croteau — formerly with Booz Allen Hamilton and General Electric, the Orthopedic division manufactures and assembles implants and instruments for the reconstructive, spinal, trauma and sports medicine markets. Both divisions will be located in the Boston area.
Located in Minneapolis, the cardiology division will be led by Sparks until a general manager is appointed. That division manufactures and assembles implants and instruments for the cardiac rhythm management, interventional, radiology/cardiology, cardiac surgery and peripheral vascular markets.